This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Barbara Giomarelli: Innovator in Platelet Modulation
Introduction
Barbara Giomarelli is a prominent inventor based in Frederick, MD (US). She has made significant contributions to the field of biomedical research, particularly in the modulation of platelet activity. Her work has implications for treating various diseases and disorders associated with platelet function.
Latest Patents
Giomarelli holds a patent for "Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions." This invention relates to methods and compositions for modulating platelet activity. It includes administering a single chain anti-TREM-like transcript-1 (TLT-1) antibody or a functional fragment or variant thereof in an effective amount to modulate platelet activity.
Career Highlights
Barbara Giomarelli is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her research focuses on innovative approaches to enhance our understanding of platelet biology and its role in various health conditions.
Collaborations
Some of her notable coworkers include Toshiyuki Mori and Daniel W McVicar. Their collaborative efforts contribute to advancing research in the field of platelet modulation.
Conclusion
Barbara Giomarelli's work exemplifies the intersection of innovation and healthcare, showcasing her dedication to improving medical treatments through her patented inventions.